SCIENTIFIC PROGRAMME of the pre-congress courses
ROOM 1
12:00 - 12:05
Introduction
Chair: Dr Jana Žodžika
12:05 - 12:35
Colposcopic principles
Speaker: Dr Annu Heinonen
12:35 - 13:00
Swede score
Speaker: Dr Björn Strander
13:00 - 13:10
Break
13:10 - 14:10
Interactive sessions
Speaker: Dr Annu Heinonen, Dr Jana Žodžika, Mr Charles Redman & Dr Björn Strander
14:10 - 14:30
Break
14:30 - 15:00
Management
Speaker: Mr Charles Redman
15:00 - 16:00
Interactive sessions
Speaker: Dr Annu Heinonen, Dr Jana Žodžika, Mr Charles Redman & Dr Björn Strander
16:00 - 16:10
Break
16:10 - 17:00
Special cases
Chair: Dr Jana Žodžika
ROOM 2
12:00 - 18:00
Training the trainers
Speakers: Dr Maggie Cruickshank, Dr Xavier Carcopino, Dr Ameli Trope & Dr Theresa Freeman-Wang
SCIENTIFIC PROGRAMME of the 9° EFC CONGRESS
ROOM 1
08:30 - 09:00
Opening Ceremony
9:00 - 10:30
MSS1: Keynote 1
Chairs: Dr Pekka Nieminen, Finland & Dr Björn Strander, Sweden
- Prophylactic vaccinations and the elimination of HPV and cervical cancer: Dr Joakim Dillner, Sweden
- Prophylactic vaccination and eradication of oncogenic HPVs.: Dr Matti Lehtinen, Finland
- Keynote Lecture 1c: HPV vaccination after treatment of CIN: Dr Maria Kyrgiou, UK
- Q&A session
10:30 - 11:00
Break
11:00 - 12:30
MSS 2: Genetics and epigenetics: from HPV to cancer
Chairs: Dr Olaf Reich, Austria & Dr Karolina Louvanto, Finland
- Genetic predisposition in cervical cancer: Dr Sarah Bowden, UK
- Temporal sequence of somatic driver gene mutations in cervical carcinogenesis: Dr Sigrid Regauer, Austria
- Epigenetic modification of cellular and HPV genomes: Dr Magnus von Knebel-Doeberitz, Germany
- HPV genetics and genotype variation: Dr Karolina Louvanto, Finland
- Q&A session
12:30 - 13:30
Break
13:30 - 15:00
MSS3: HPV screening now
Chairs: Dr Ameli Trope, Norway & Dr Marc Arbyn, Belgium
- Validated hpv tests for screening: Dr Kate Cuschieri, UK
- Triage of HPV+ in Denmark: Dr Jesper Bonde, Denmark
- Self sampling: Dr Marc Arbyn, Belgium
- Experience of self-sampling in the NL: Dr Sandra Van Dijk, The Netherlands
- Q&A session
15:00 - 15:30
Break
15:30 - 17:00
MCS 3: Challenges in screening, diagnostic and follow-up: persistent HPV & posmenopausal women
Chairs: Dr Xavier Carcopino, France & Dr Anne Hammer, Denmark
- Evidence for latent papillomavirus infections and their regulation: Dr John Doorbar, UK
- Risk of HSIL and cancer in postmenopausal women and after cessation of screening: Dr Miriam Elfström, Sweden
- Best management options for women with type 3 TZ: Dr Anne Hammer, Denmark
- Dealing with persistent HPV following treatment of CIN: Dr Amelia Pedro, Portugal
- Q&A session
17:00 - 17:30
Break
17:30 - 19:00
Virtual get together
ROOM 2
08:30 - 09:00
Opening Ceremony
09:00 - 10:00
Break
10:00 - 11:30
MCS 1: Follow-up and conservative treatment of CIN or SIL
Chairs: Dr Christine Bergeron, France & Dr Karoliina Aro, Finland
- Post-treatment follow-up of CIN, test of cure and prognostic factors: Dr Efraim Siegler, Israel
- Regression rate of HSIL of the cervix in women under the age of 25 years: Dr Monika Hampl, Germany
- Conservative management of LSIL and CIN2 lesions: Dr Karoliina Aro, Finland
- Alternative treatments for low grade lesions: Dr Peter Hillemans, Germany
- The long term risk of HPV-related disease after CIN3 treatment: Dr Diede Loopik, The Netherlands
- Q&A session
11:30 - 12:30
Break
12:30 - 14:00
MCS 2: Management of CIN
Chairs: Dr Evangelos Paraskevaidis, Greece & Mr Simon Leeson, UK
- Cancer rate and recurrence after local treatment, comparisons between different methods: Dr Antonis Athanasiou, UK
- Repeat local treatments, when, to whom and associated morbidity: Dr Pierre Martin-Hirsch, UK
- Increased risk of cervical cancer post treatment and possible explanations: Dr Björn Strander, Sweden
- Personalised management of women with cervical pathology incorporating lifestyle algorithms: Dr Evangelos Paraskevaidis, Greece
- Q&A session
14:00 - 14:30
Break
14:30 - 15:00
Free Communications 1
15:00 - 15:30
Break
15:30 - 17:00
Colposcopy in practice – Cases 1
Chairs: Dr Robert Koiss, Hungary & Dr Marja Simojoki, Finland
- Use of Iodine in colposcopy + introduction to SWEDE-score: Dr Björn Strander
- Interactive cases: Several presentations
17:00 - 17:30
Break
17:30 - 19:00
Virtual get together
ROOM 3
08:30 - 09:00
Opening Ceremony
09:00 - 10:00
Colposcopy in the era of HPV vaccination – vulva and anus
Chairs: Dr Jacob Bornstein, Israel & Dr Maggie Cruickshank, UK
- Diagnosis and treatment of AIN: Dr Tamzin Cuming, UK
- Diagnosis and treatment of VIN: Dr J Bornstein, Israel
- Q&A session
10:00 - 10:30
Break
10:30 - 12:00
Diagnostic Challenges of various vulvar symptoms
Chairs: Dr Päivi Tommola, Finland & Dr Eija Hiltunen-Back, Finland
- Genital ulcers, differential diagnostics: Dr Eija Hiltunen-Back, Finland
- What we know of and diagnostic challenges in vulvodynia: Dr Päivi Tommola, Finland
- Acetic acid and vulva: clinical relevance: Dr Pia Halonen, Finland
- Q&A session
12:00 - 13:00
Break
13:00 - 14:30
Vaginal Microbiome
Chairs: Dr Gilbert Donders, Belgium & Dr Jana Žodžika, Latvia
- Cervical disease and vaginal microbiome: the systems biology: Dr Maria Kyrgiou, UK
- HPV and fertility: Dr Gilbert Donders, Belgium
- Different vaginal microflora types and CIN: Dr Olga Plisko, Latvia
- Q&A session
14:30 - 15:00
Break
15:00 - 15:30
Free Communications 2
16:00 - 16:30
Break
16:30 - 17:30
Vaginal HSIL
Chairs: Dr Andrea Ciavattini, Italy & Dr Maija Jakobsson, Finland
- HPV vaccination and vaginal HSIL lesions: Dr Jorma Paavonen, Finland
- Imiquimod treatment for vaginal HSIL: Dr Karoliina Aro, Finland
- Evidence-based treatment of vaginal HSIL: Dr Francesco Sopracordevole, Italy
- Q&A session
17:30 - 18:30
Break
17:30 - 19:00
Virtual get together
ROOM 1
08:30 - 09:00
Break
9:00 - 10:30
MCS 4: Colposcopy and CIN during pregnancy
Chairs: Dr Efraim Siegler, Israel & Dr Mihaela Grigore, Romania
- HPV and complications in pregnancy: Dr Anita Mitra, UK
- Vertical transmission of HPV during pregnancy – what do we know?: Dr Mihaela Grigore, Romania
- The difficulty of cervical cancer prevention by pap and colposcopy during pregnancy: Dr Cecilia Kärrberg, Sweden
- The outcome of CIN 2-3 in pregnancy? The best way of delivery: Dr Zvi Vaknin, Israel
- Should CIN 2-3 be treated in pregnancy?: Dr Efraim Siegler, Israel
- Q&A session
10:30 - 11:00
Break
11:00 - 12:30
MCS 6: Special cases in pathology, colposcopy, and treatment
Chairs: Dr Olaf Reich, Austria & Dr Laura Kotaniemi-Talonen, Finland
- Immune microenvironment in SIL of the cervix: Dr Ruud Bekkers, The Netherlands
- HPV-independent cervical cancer and precancer: Dr Miriam Elfström, Sweden
- New concepts in excisional treatment of HSIL and AIS: Dr Olaf Reich, Austria
- Challenges on the way of elImination of cervical cancer in Eastern Europa: Dr Natalia Volodko, Ukraine
- Q&A session
12:30 - 13:30
Break
13:30 - 15:00
MSS 4: Prophylactic HPV-vaccines
Chairs: Dr Ruud Bekkers, The Netherlands & Dr Ilkka Kalliala, Finland
- HPV type replacement after prophylactic vaccination: Dr Penelope Gray, Finland
- HPV vaccines, CIN and preterm birth: Dr Ilkka Kalliala, Finland
- Self sampling: Dr Marc Arbyn, Belgium
- Experience of self-sampling in the NL: Dr Sandra Van Dijk, The Netherlands
- HPV vaccination for high-risk adult women, including after CIN treatment: Dr Heleen van Beekhuizen, The Netherlands
- Screening after HPV vaccination: Dr Peter Sasieni, UK
- Q&A session
15:00 - 15:30
Break
15:30 - 16:30
Free Communications 5 (OP)
16:30 - 18:00
Break
19:00
Prizes
ROOM 2
08:30 - 09:30
Colposcopy in practice – Cases 2
Chairs: Dr Tamar Alibegashvili, Georgia & Dr Annu Heinonen, Finland
- Interactive cases: Several presentations
09:30 - 10:00
Break
10:00 - 11:30
MCS 5: Keynote 2: future of screening and colposcopy
Chairs: Dr Maggie Cruickshank, UK & Dr Xavier Carcopino, France
- Keynote Lecture 2a: The future of cervical cancer screening: Dr Mari Nygård, Norway
- Keynote Lecture 2b: Triage and prognostic markers in cervical cancer screening: Dr Cara Martin, Ireland
- Keynote Lecture 2c: QA of colposcopy for HPV-based screening programmes and HPV-vaccinated populations: Mr Simon Leeson, UK
- Q&A session
11:30 - 12:30
Break
12:30 - 14:00
MCS 7: Guidelines and QI for colposcopy in Europe
Chairs: Mr Simon Leeson, UK & Mr Charles Redman, UK
- European guidelines, where we are, the importance of consensus and linkage to QIs: Dr Maggie Cruickshank, UK
- Influence of international guidelines: Dr Jean-Luc Mergui, France
- Quality Indicators: relevant and reproducible?: Mr Simon Leeson, UK
- Implementing international guidelines locally. The value of incorporation of international into national guidelines: Dr Maciej Mazurec, Poland
- Q&A session
14:00 - 14:30
Break
14:30 - 15:30
Free Communications 4 (OP)
15:30 - 16:00
Break
16:00 - 17:30
MSS 5: The male factor in HPV transmission and vaccination programmes
Chairs: Dr Kristina Elfgren, Sweden & Dr Wiebren Tjalma, Belgium
17:30 - 18:00
Break
19:00
Prizes
ROOM 3
08:30 - 10:00
Free Communications 3
10:00 - 10:30
Break
10:30 - 12:00
Cervical Cancer Screening Audit and Medico-legal issues
Chairs: Mr Charles Redman, UK & Dr Volkmar Küppers, Germany
- The potential of national cancer screening audit: Dr Peter Sasieni, UK
- Swedish cancer screening audits: Dr Miriam Elfström, Sweden
- English cancer screening audits: Dr Phillippa Pearman, UK
- Disclosure of cervical cancer audit findings: Dr Theresa Freeman-Wang, UK
- Q&A session
12:00 - 13:00
Break
13:00 - 14:30
Cervical cancer prevention in underscreened countries
Chairs: Dr Robert Jach, Poland, & Dr Jana Žodžika, Latvia
- Prevention of cervical cancer in Serbia – opportunities and limitations: Dr Vesna Kesic, Serbia
- How can we improve adherence to the screening?: Dr Michaela Grigore, Romania
- Challenges of cervical cancer screening programme in Lithuania: Dr Kristina Jariene, Lithuania
- HPV test as a primary screening tool in all resource settings (The Balkan Perspective): Dr Goran Dimitrov, Northern Macedonia
- Is organized population-based model the universal strategy for all underscreened populations? – hybrid screening strategy as a chance for Poland: Dr Martyna Trzeszcz, Poland
- Q&A session
14:30 - 15:00
Break
15:00 - 16:30
EFC General Assembly
16:30 - 18:00
Break
19:00
Prizes
ROOM 1
9:00 - 10:30
MCS 8: Improving selection of new technologies in colposcopy
Chairs: Mr Charles Redman, UK & Dr Tamar Alibegashvili, Georgia
- Presentation of the Ulli Petry Prize: Dr Pekka Nieminen, Finland
- Risk-based management focused on risk stratification – a multi parameter approach: Dr Martyna Trzeszcz, Poland
- Improving diagnosis with Zedscan: Dr John Tidy, UK
- Improving diagnosis with Dysis: Dr Jacqueline Louwers, The Netherlands
- The potential role of AI in the Polish context: Dr Robert Jach, Poland
- Q&A session
10:30 - 11:00
Break
11:00 - 12:30
MCS 9: Media coverage and social media
Chairs: Dr Ameli Trope, Norway & Dr Grainne Flannelly, Ireland
- Setting the scene – The role of media and social media in establishing trust in cervical cancer prevention programmes: Dr Grainne Flannelly, Ireland
- What women know about HPV and lessons learned about how this might affect uptake of a HPV based cervical screening programme: Dr Mairead O’Connor, Ireland
- The use of social media campaigns to drive uptake of cervical screening in the UK: Dr Samantha Dickson, UK
- Risk and benefits of LLETZ – what women really think and what lessons can we learn about influencing behaviour and establishing trust: Dr Ameli Trope, Norway
- Using social media campaigns to tackle disinformation about HPV vaccination – a strategy that worked: Dr Muiriosa Ryan, Ireland
12:30 - 13:30
Closing remarks & Awards
ROOM 2
09:00 - 10:30
MSS 6: Impact of Covid-19 on cervical screening, prevention and prognosis
Chairs: Mr Simon Leeson, UK & Dr Xavier Carcopino, France
- Impact of Covid-19 outbreak on cervical cancer screening throughout Europe: Dr Xavier Carcopino, France
- BSCCP colposcopy training and the exit exam and what was done during Covid: Dr Deirdre Lyons, UK
- Early lessons from the coronavirus pandemic for the cervical screening programme in Wales: Mr Simon Leeson, UK
- Experience from the Netherlands with Covid and self-sampling: Dr Anne-Marie van Haaften-de-Jong, The Netherlands
- Q&A session
10:30 - 11:00
Break
11:00 - 12:30
Round Table on The future roles for the EFC
Chairs: Dr Jens Quaas, Germany; Dr Rino Barbero, Italy; Mr Charles Redman, UK; Dr Pekka Nieminen, Finland & Dr Margaret Cruickshank, UK
What are the future priorities for the EFC and how should the EFC achieve these: Dr Robert Jach, Germany; Dr Volkmar Küppers, Germany; Dr Amelia Pedro, Portugal & Dr Ilkka Kalliala, Finland